Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90Yttrium-DOTA-peptide-ChL6

Robert T O'Donnell, Sally J. Denardo, Laird A. Miers, Kathleen R. Lamborn, David L. Kukis, Gerald L Denardo, Frederick J Meyers

Research output: Contribution to journalArticlepeer-review

60 Scopus citations

Fingerprint Dive into the research topics of 'Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and <sup>90</sup>Yttrium-DOTA-peptide-ChL6'. Together they form a unique fingerprint.

Medicine & Life Sciences